The Mass General Brigham Biobank aims to foster collaborations among investigators, physicians and patients seen at Mass General Brigham institutions. This enterprise-wide project is at the forefront of developing the tools needed to expedite research and the translation of discoveries into clinical care such as polygenic and pharmacogenetic risk scores.

Samples are maintained in an institution-wide repository which is a growing resource available to Mass General Brigham investigators and research groups. These samples are available for distribution to Mass General Brigham investigators with required approval from the Mass General Brigham Institutional Review board (IRB). They are linked to clinical data, some additional health information and survey data, and genomic data. The Mass General Brigham Biobank is also driving a program to genotype 40,000 of the Biobank’s participants.

To date, more than 120,000 patients have consented to participate in the Mass General Brigham Biobank at hospitals and clinics across the Mass General Brigham system, including Brigham and Women’s Hospital, Massachusetts General Hospital, Mass Eye and Ear Infirmary, Faulkner Hospital, Newton-Wellesley Hospital, McLean Hospital, North Shore Medical Center and Spaulding Rehabilitation Network.

Please visit Mass General Brigham Personalized Medicine to learn more about how the Mass General Brigham Biobank can help you with your research.

Please visit the Biobank wiki for step-by-step instructions to make sample and data requests (you must be on the Mass General Brigham network to view this website).